Fraunhofer develops new bio-inks for 3D organ printing

The Fraunhofer Institute in Germany is developing new bio-inks for the 3D printing of tissues and organs, aiming to address limitations in current bioprinting methods. The research initiative, known as PhysioINK, focuses on creating bio-inks that more closely mimic the physiological structure and composition of human organs.

Existing bio-inks often present a trade-off: either good printability but poor replication of natural tissue structures, or vice versa. Researchers from various Fraunhofer institutes (ISC, IAP, IMWS, and IZI) are collaborating to overcome this challenge. Their goal is to develop sustainable and process-optimized bio-inks capable of precisely replicating physiological human organ structures and compatible with various 3D printing techniques.

The project plans to develop two primary applications: standardized intestinal tumor models for drug development and physiological cardiac tissue as a step toward functional implants for personalized regenerative medicine. Instead of using synthetic or chemically modified materials, the researchers are utilizing common tissue proteins like collagen and elastin. These proteins are initially stabilized by cellulose sulfates, keeping them dissolved and printable. A subsequent temperature trigger then initiates the proteins' self-organization into their natural fibrous or network-like structures.

The PhysioINK project focuses on creating highly concentrated, protein-based printing inks from collagen and elastin. These inks maintain a neutral pH and physiological properties, offering excellent biocompatibility with human cells. This research endeavors to significantly improve the ability to replicate natural organ structures via 3D bioprinting, potentially aiding in alleviating organ shortages and advancing medical research.